You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

PRILOCAINE HYDROCHLORIDE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Prilocaine Hydrochloride patents expire, and when can generic versions of Prilocaine Hydrochloride launch?

Prilocaine Hydrochloride is a drug marketed by Septodont Inc and is included in two NDAs.

The generic ingredient in PRILOCAINE HYDROCHLORIDE is epinephrine bitartrate; prilocaine hydrochloride. There are twenty-one drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the epinephrine bitartrate; prilocaine hydrochloride profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for PRILOCAINE HYDROCHLORIDE?
  • What are the global sales for PRILOCAINE HYDROCHLORIDE?
  • What is Average Wholesale Price for PRILOCAINE HYDROCHLORIDE?
Drug patent expirations by year for PRILOCAINE HYDROCHLORIDE
Recent Clinical Trials for PRILOCAINE HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Assiut UniversityN/A
Indonesia Endowment Fund for EducationPhase 4
Universitas Sebelas MaretPhase 4

See all PRILOCAINE HYDROCHLORIDE clinical trials

Pharmacology for PRILOCAINE HYDROCHLORIDE
Drug ClassAmide Local Anesthetic
Physiological EffectLocal Anesthesia
Medical Subject Heading (MeSH) Categories for PRILOCAINE HYDROCHLORIDE
Anatomical Therapeutic Chemical (ATC) Classes for PRILOCAINE HYDROCHLORIDE

US Patents and Regulatory Information for PRILOCAINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Septodont Inc PRILOCAINE HYDROCHLORIDE prilocaine hydrochloride INJECTABLE;INJECTION 079235-001 Sep 29, 2010 RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Septodont Inc PRILOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE epinephrine bitartrate; prilocaine hydrochloride INJECTABLE;INJECTION 078959-001 Aug 30, 2011 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.